Protease Targets & Drug Discovery, Philadelphia, PA, USA
Event Dec 08
The goal of the conference is to illustrate new areas of protease target investigations in the nervous system for health and disease, and to demonstrate how established protease mechanisms in the infectious disease field has led to discovery of effective therapeutic agents for these
detrimental health conditions,” explains Chairperson Vivian Hook, Ph.D. of the Buck Institute and UC San Diego.
Presenting these agents to the delegates will be leaders from the industry and academia. Research involving protease targets investigations in the nervous system for health and disease, viral proteases, cancer, coagulation, and Alzheimer’s disease will outline the agenda. Highlighting the event will be key researchers from leading companies including Abbott, Eli Lilly, GlaxoSmithKline, Merck, Roche, and Schering-Plough.
2nd Annual Artificial Intelligence in Drug Development Congress
Sep 20 - Sep 21, 2018